Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-label Extension Study to Assess the Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

NCT02764229 is registered in ClinicalTrials.gov with Lycera Corp. as lead sponsor.

NCT NCT02764229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02764229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-label Extension Study to Assess the Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Lead sponsor
Lycera Corp.
Phase
Phase 2
Overall status
Terminated
Start date
November 1, 2016
Completion date
July 18, 2018
Enrollment
112 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative